Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial
- Resource Type
- Source
- Airway pharmacology and treatment.
- Subject
medicine.medical_specialty COPD business.industry Internal medicine medicine Placebo-controlled study Pulmonary disease medicine.disease business Gastroenterology - Language